Bupropion and naltrexone for smoking cessation: A double-blind randomized placebo-controlled clinical trial.

Mooney, M E

Bupropion and naltrexone for smoking cessation: A double-blind randomized placebo-controlled clinical trial. [electronic resource] - Clinical pharmacology and therapeutics 10 2016 - 344-52 p. digital

Publication Type: Journal Article; Randomized Controlled Trial; Research Support, N.I.H., Extramural

1532-6535

10.1002/cpt.402 doi


Adult
Antidepressive Agents, Second-Generation--adverse effects
Bupropion--adverse effects
Double-Blind Method
Drug Therapy, Combination--adverse effects
Female
Humans
Male
Naltrexone--adverse effects
Narcotic Antagonists--adverse effects
Patient Compliance
Smoking--drug therapy
Smoking Cessation--methods
Substance Withdrawal Syndrome--drug therapy
Treatment Outcome
Young Adult